CT
Calliditasd Therapeutics AB Stock: price and insider trades · Sweden
No insider purchase over the last 90 days. The latest, by Jens Kristensen, was filed 21 Dec 2018.
Calliditasd Therapeutics AB: what insiders have been doing
Insider filings for Calliditasd Therapeutics AB are scarce in the Finansinspektionen feed, the latest one published on 21 December 2018. This page will fill in as new trades are disclosed. Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.
Insider Decl.
1
Thresholds
n/a
Buy Volume
€15,962
1 ops. · all time
Sell Volume
n/a
n/a
Financial data
· cache
Last declaration on 21 December 2018
Declarations1 total
- 50,000 shares@ SEK 3.29100.0% of flowTeckningsoptionFI:csv-9f014a59a21882d6c401Canonical exit: 19 Mar 2019 (T+90)
1 of 1 declaration
About Calliditasd Therapeutics AB
Calliditas Therapeutics AB is a biopharmaceutical company focused on developing treatments for rare kidney diseases. It is listed on the Stockholm Stock Exchange.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations